(Q38235918)

31 August 2017

title

Mechanisms of tissue injury in autoimmune liver diseases (English)

1 reference

31 August 2017

author

Gideon M. Hirschfield

series ordinal

2

1 reference

31 August 2017

3

M Eric Gershwin

1 reference

31 August 2017

Evaggelia Liaskou

1

1 reference

31 August 2017

publication date

1 August 2014

1 reference

Seminars in Immunopathology

31 August 2017

published in

1 reference

31 August 2017

volume

36

1 reference

31 August 2017

issue

5

1 reference

31 August 2017

page(s)

553-568

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-014-0439-3

31 August 2017

exact match

0 references

cites work

The immunobiology and pathophysiology of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Review article: overlap syndromes and autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Mucosal immunity in liver autoimmunity: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Cutting edge issues in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

A familial case of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genome-wide association analysis in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Immune-mediated diseases in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoimmune liver disease, autoimmunity and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genetics of liver disease: immunogenetics and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The genetics of complex cholestatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Genetics in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Novel insights into autoimmune liver diseases provided by genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Criteria for environmentally associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoimmune hepatitis: the role of environmental risk factors: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Smoking, family history and urinary tract infection are associated with primary biliary cirrhosis: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The X and why of xenobiotics in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoantibodies and their antigens in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Cutting-edge issues in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoantibodies against "nuclear dots" in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Pathogenesis of primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Lymphocyte homing and its role in the pathogenesis of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Etiopathogenesis of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Role of gut microbiota in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Mechanisms of disease: a 'DAMP' view of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The dynamic biliary epithelia: molecules, pathways, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autoantibodies in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Implication for functions of the ectopic adipocyte copper amine oxidase (AOC3) from purified enzyme and cell-based kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

CCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The chemokine stromal cell-derived factor-1 alpha modulates alpha 4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Connecting liver and gut: murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Concurrent autoimmune diseases in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

ATP drives lamina propria T(H)17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Control of TH17 cells occurs in the small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The plasticity and stability of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Regulatory T cells in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Loss of Inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

The cholangiopathies: disorders of biliary epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

A blast from the past: clearance of apoptotic cells regulates immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Increased TERC gene copy number and cells in senescence in primary sclerosing cholangitis compared to colitis and control patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Animal models of primary biliary cirrhosis: materials and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-014-0439-3

MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)

21 January 2018

1 reference

12 December 2020

Immunohistochemical analysis of inflammation in primary sclerosing cholangitis.

1 reference

12 December 2020

Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells

1 reference

12 December 2020

T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis

1 reference

12 December 2020

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis

1 reference

12 December 2020

Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis

1 reference

12 December 2020

Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis

1 reference

12 December 2020

T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis

1 reference

12 December 2020

Primary biliary cirrhosis

1 reference

12 December 2020

Etiopathogenesis of primary sclerosing cholangitis

1 reference

12 December 2020

Accumulation of macrophages in primary sclerosing cholangitis

1 reference

12 December 2020

Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis

1 reference

12 December 2020

Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss

1 reference

12 December 2020

Genetic distinctions between types 1 and 2 autoimmune hepatitis

1 reference

12 December 2020

HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study

1 reference

12 December 2020

Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis.

1 reference

12 December 2020

p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ

1 reference

12 December 2020

Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis

1 reference

12 December 2020

Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis

1 reference

12 December 2020

Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage

1 reference

12 December 2020

Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms

1 reference

12 December 2020

Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases

1 reference

12 December 2020

Novel approach to bile duct damage in primary biliary cirrhosis: participation of cellular senescence and autophagy

1 reference

12 December 2020

Increased prevalence of primary sclerosing cholangitis among first-degree relatives

1 reference

12 December 2020

IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy

1 reference

12 December 2020

Lymphocyte subpopulations in peripheral blood in primary sclerosing cholangitis

1 reference

12 December 2020

Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis

1 reference

12 December 2020

Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence

1 reference

12 December 2020

Abnormal intestinal permeability in primary biliary cirrhosis

1 reference

12 December 2020

Two sister cases of autoimmune hepatitis.

1 reference

12 December 2020

Two cases of inflammatory bowel disease diagnosed in the course of primary biliary cirrhosis

1 reference

12 December 2020

10.1007/S00281-014-0439-3

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1010149372

0 references

1 reference